AnisatinCAS# 5230-87-5 |
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
| Cas No. | 5230-87-5 | SDF | Download SDF |
| PubChem ID | 115121 | Appearance | White powder |
| Formula | C15H20O8 | M.Wt | 328.3 |
| Type of Compound | Isoprenoids | Storage | Desiccate at -20°C |
| Solubility | Soluble in ethyl acetate; slightly soluble in water | ||
| SMILES | CC1CC(C2(C13CC(C(C24COC4=O)(C)O)OC(=O)C3O)O)O | ||
| Standard InChIKey | GEVWHIDSUOMVRI-QWNPAUMXSA-N | ||
| Standard InChI | InChI=1S/C15H20O8/c1-6-3-7(16)15(21)13(6)4-8(23-10(18)9(13)17)12(2,20)14(15)5-22-11(14)19/h6-9,16-17,20-21H,3-5H2,1-2H3/t6-,7-,8-,9+,12+,13+,14+,15-/m1/s1 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
Anisatin Dilution Calculator
Anisatin Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 3.046 mL | 15.23 mL | 30.4599 mL | 60.9199 mL | 76.1499 mL |
| 5 mM | 0.6092 mL | 3.046 mL | 6.092 mL | 12.184 mL | 15.23 mL |
| 10 mM | 0.3046 mL | 1.523 mL | 3.046 mL | 6.092 mL | 7.615 mL |
| 50 mM | 0.0609 mL | 0.3046 mL | 0.6092 mL | 1.2184 mL | 1.523 mL |
| 100 mM | 0.0305 mL | 0.1523 mL | 0.3046 mL | 0.6092 mL | 0.7615 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Flavoglaucin
Catalog No.:BCN6398
CAS No.:523-73-9
- Evolitrine
Catalog No.:BCN8350
CAS No.:523-66-0
- Angelicin
Catalog No.:BCN5669
CAS No.:523-50-2
- 4-Amino-2,5-dimethoxy-N-phenylbenzenesulphonamide
Catalog No.:BCC8676
CAS No.:52298-44-9
- Ginsenoside Rg2
Catalog No.:BCN1067
CAS No.:52286-74-5
- Ginsenoside Re
Catalog No.:BCN1073
CAS No.:52286-59-6
- Ginsenoside Rf
Catalog No.:BCN1075
CAS No.:52286-58-5
- 3,5-Diprenyl-4-hydroxybenzaldehyde
Catalog No.:BCN4624
CAS No.:52275-04-4
- CGP 57380
Catalog No.:BCC5279
CAS No.:522629-08-9
- Isomucronulatol
Catalog No.:BCN1428
CAS No.:52250-35-8
- Parathyroid hormone (1-34) (human)
Catalog No.:BCC1046
CAS No.:52232-67-4
- Kaempferol-4'-O-beta-D-glucopyranoside
Catalog No.:BCN8130
CAS No.:52222-74-9
- Vindorosine
Catalog No.:BCN5668
CAS No.:5231-60-7
- p,p-hydroxy-curucumin
Catalog No.:BCC8890
CAS No.:52328-96-8
- Tetramethylcurcumin
Catalog No.:BCN2746
CAS No.:52328-97-9
- Dimethylcurcumin
Catalog No.:BCN2748
CAS No.:52328-98-0
- 6alpha-Chloro-5beta-hydroxywithaferin A
Catalog No.:BCN8007
CAS No.:52329-20-1
- Alnusone
Catalog No.:BCN8108
CAS No.:52330-11-7
- 2-Benzoyl-1,3,4,4a,5,8a-hexahydro-6(2H)-isoquinolinone
Catalog No.:BCC8559
CAS No.:52346-14-2
- Erysotramidine
Catalog No.:BCN5670
CAS No.:52358-58-4
- Epistephamiersine
Catalog No.:BCN5671
CAS No.:52389-15-8
- Wedelolactone
Catalog No.:BCN5672
CAS No.:524-12-9
- gamma-Fagarine
Catalog No.:BCN5673
CAS No.:524-15-2
- Dauricine
Catalog No.:BCN4977
CAS No.:524-17-4
A bird's eye view of anisatin induced convulsive seizures in brain by a (1)H NMR based metabolic approach.[Pubmed:25133938]
Mol Biosyst. 2014 Nov;10(11):2923-34.
Anisatin is the main convulsant component in plants of the genus Illicium, many of which are important spices or folk medicines. The neurotoxicity of Anisatin has been widely investigated, mainly focusing on its action on the gamma-amino butyrate (GABA) system; however, little is known about the metabolic alterations that it causes. In this study, a NMR-based metabolomic approach was performed on the extracts of cortexes and cerebellums of mice administered with Anisatin to explore the metabolic events associated with its intoxication. Orthogonal partial least squares-discriminant analysis (OPLS-DA) revealed many differential metabolites that indicated metabolic disturbance in neurotransmission and neuromodulation (GABA, glutamate, glutamine, and taurine), stress of reactive oxygen species (ROS) (ascorbate, phosphatidylcholine, choline, and ethanolamine), energy metabolism (NAD(+)i.e., nicotinamide-adenine dinucleotide, lactate, citrate, fumarate, creatine/phosphocreatine, and creatinine), amino acid metabolism (leucine, isoleucine, valine, phenylalanine, tyrosine, tryptophan, alanine, threonine, and glycine) and nucleic acid metabolism (NAD(+), nicotinamide/niacinamide, adenosine, and guanosine). This pilot metabolomic study on Anisatin intoxication should help to develop a holistic view of convulsive seizures induced by Anisatin, and provide a better understanding of the mechanisms.
